PHM vs TARS · P/E 7.7, rev $7.39B vs rev $336.0M
PulteGroup Inc (PHM) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
PHM currently screens at market cap $21.92B and trailing P/E 7.7. TARS currently screens at market cap $2.66B.
Not investment advice. Open the PHM and TARS stock pages for the full models.
Not investment advice.